These observations are far too limited to draw any conclusions, especially as the incidence of cancer is increasing globally and also varies within different ethnic groups, but should prompt additional systematic prospective studies, to obtain more robust data concerning a potential association between the EPG5 carrier state, and neoplastic and neurodegenerative disorders, respectively. This evidence concerns the gene EPG5 and cancer.